Feline B7.1 and B7.2 proteins produced from swinepox virus vectors are natively processed and biologically active: Potential for use as nonchemical adjuvants

Veterinary Microbiology

Volumn 111, Issue 1-2, 2005, Pages 1-13

  Winslow, Barbara J ^a   Kalabat, Dalia Y ^a   Brown, Scott M ^b   Cochran, Mark D ^a   Collisson, Ellen W ^c  

^a Schering Plough Anim Hlth Corp   (United States)

^b Biologies Process Development   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Adjuvant; Costimulatory molecules; Feline B7.1; Feline B7.2; Mammalian expression vector; Swinepox virus

Indexed keywords

ANTINEOPLASTIC AGENT; B7.1 PROTEIN; B7.2 PROTEIN; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 2; LIGAND; POLYHISTIDINE; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CAT; CHROMATOGRAPHY; CYTOPLASM; FELINE LEUKEMIA VIRUS; LEUKEMIA CELL LINE; NONHUMAN; PROTEIN PURIFICATION; RECEPTOR BINDING; SWINEPOX VIRUS; TISSUE CULTURE; VIRUS GENE; VIRUS STRAIN;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; CATS; CELL LINE; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; GENETIC VECTORS; HUMANS; IMMUNOCONJUGATES; INTERLEUKIN-2; JURKAT CELLS; LEUKEMIA, FELINE; LYMPHOCYTE ACTIVATION; POXVIRIDAE INFECTIONS; SUIPOXVIRUS; VIRUS REPLICATION;

ANIMALIA; FELIDAE; FELINE LEUKEMIA VIRUS; MAMMALIA; SUS SCROFA; SWINEPOX VIRUS; SWINEPOX VIRUS (STRAIN KASZA);

EID: 27644555068     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2005.06.008     Document Type: Article

References (63)

1. C.L. Afonso, E.R. Tulman, Z. Lu, L. Zsak, F.A. Osorio, C. Balinsky, G.F. Kutish, and D.L. Rock The genome of swinepox virus J. Virol. 76 2002 783 790
2. M.L. Alegre, K.A. Frauwirth, and C.B. Thompson T-cell regulation by CD28 and CTLA-4 Nat. Rev. Immunol. 1 2001 220 228
3. M. Azuma, D. Ito, H. Yagita, K. Okumura, J.H. Phillips, L.L. Lanier, and C. Somoza B70 antigen is a second ligand for GTLA-4 and CD28 Nature 366 1993 76 79
4. M.W. Carroll, and B. Moss E. coli beta-glucuronidase (GUS) as a marker for recombinant vaccinia viruses Biotechniques 19 1995 352-354, 356
5. S. Cayeux, G. Richter, G. Noffz, B. Dorken, and T. Blankenstein Influence of gene-modified (IL-7, IL-4 and B7) tumor cell vaccines on tumor antigen presentation J. Immunol. 158 1997 2834 2841
6. C.A. Chambers The expanding world of co-stimulation: the two-signal model revisited Trends Immunol. 22 2001 217 223
7. I.S. Choi, S.M. Hash, and E.W. Collisson Molecular cloning and expression of feline CD28 and CTLA-4 cDNA Vet. Immunol. Immunopathol. 76 2000 45 59
8. I.S. Choi, S.M. Hash, B.J. Winslow, and E.W. Collisson Sequence analyses of feline B7 costimulatory molecules Vet. Immunol. Immunopathol. 73 2000 219 231
9. M. Corr, H. Tighe, D. Lee, J. Dudler, M. Trieu, D.C. Brinson, and D.A. Carson Costimulation provided by DNA immunization enhances antitumor immunity J. Immunol. 159 1997 4999 5004
10. A.J. Coyle, and J.C. Gutierrez-Ramos The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function Nat. Immunol. 2 2001 203 209
11. T.A. Davis, N. Craighead, A.J. Williams, A. Scadron, C.H. June, and K.P. Lee Primary porcine endothelial cells express membrane-bound B7-2 (CD86) and a soluble factor that co-stimulate cyclosporin A-resistant and CD28-dependent human T cell proliferation. Int. Immunol. 8 1996 1099 1111
12. P.C. Emtage, Y. Wan, J.L. Bramson, F.L. Graham, and J. Gauldie A double recombinant adenovirus expressing the costimulatory molecule B7-1 (murine) and human IL-2 induces complete tumor regression in a murine breast adenocaranoma model J. Immunol. 160 1998 2531 2538
13. S.J. Faas, M.A. Giannoni, A.P. Mickle, C.L. Kiesecker, D.J. Reed, D. Wu, W.L. Fodor, J.P. Mueller, L.A. Matis, and R.P. Rother Primary structure and functional characterization of a soluble, alternatively spliced form of B7-1 J. Immunol. 164 2000 6340 6348
14. J. Flo, S. Tisminetzky, and F. Baralle Modulation of the immune response to DNA vaccine by co-delivery of costimulatory molecules Immunology 100 2000 259 267
15. K.A. Frauwirth, and C.B. Thompson Activation and inhibition of lymphocytes by costimulation J. Clin. Invest. 109 2002 295 299
16. G.J. Freeman, V.A. Boussiotis, A. Anumanthati, G.M. Bernstein, X.Y. Ke, P.D. Rennert, G.S. Gray, J.G. Gribben, and L.M. Nadler B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4 Immunity 2 1995 523 532
17. E.A. Greenfield, K.A. Nguyen, and V.K. Kuchroo CD28/B7 costimulation: a review Crit. Rev. Immunol. 18 1998 389 418
18. N.L. Harris, and F. Ronchese The role of B7 costimulation in T-cell immunity Immunol. Cell Biol. 77 1999 304 311
19. J.W. Hodge, and J. Schlom Costimulatory molecules in vaccine design Ernst Schering Res. Found. Workshop 30 2000 23 52
20. D.E. Hruby, and G. Thomas Use of vaccinia virus to express biopharmaceutical products Pharm. Res. 4 1987 92 97
21. S. Ikemizu, R.J. Gilbert, J.A. Fennelly, A.V. Collins, K. Harlos, E.Y. Jones, D.I. Stuart, and S.J. Davis Structure and dimerization of a soluble form of B7-1 Immunity 12 2000 51 60
22. + cytotoxic T lymphocytes in vitro Hum. Gene Ther. 9 1998 1335 1344
23. A. Iwasaki, B.J. Stiernholm, A.K. Chan, N.L. Berinstein, and B.H. Barber Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines J. Immunol. 158 1997 4591 4601
24. P. Jeannin, G. Magistrelli, J.P. Aubry, G. Caron, J.F. Gauchat, T. Renno, N. Herbault, L. Goetsch, A. Blaecke, P.Y. Dietrich, J.Y. Bonnefoy, and Y. Delneste Soluble CD86 is a costimulatory molecule for human T lymphocytes Immunity 13 2000 303 312
25. C.M. Jenh, M. Zhang, M. Wiekowski, J.C. Tan, X.D. Fan, V. Hegde, M. Patel, R. Bryant, S.K. Narula, P.J. Zavodny, and C.C. Chou Development of a CD28 receptor binding-based screen and identification of a biologically active inhibitor Anal. Biochem. 256 1998 47 55
26. C.H. June, J.A. Bluestone, L.M. Nadler, and C.B. Thompson The B7 and CD28 receptor families Immunol. Today 15 1994 321 331
27. J.J. Kim, M.L. Bagarazzi, N. Trivedi, Y. Hu, K. Kazahaya, D.M. Wilson, R. Giccarelli, M.A. Chattergoon, K. Dang, S. Mahalingam, A.A. Chalian, M.G. Agadjanyan, J.D. Boyer, B. Wang, and D.B. Weiner Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes Nat. Biotechnol. 15 1997 641 646
28. J.J. Kim, L.K. Nottingham, D.M. Wilson, M.X. Bagarazzi, A. Tsai, L.D. Morrison, A. Javadian, A.A. Chalian, M.G. Agadjanyan, and D.B. Weiner Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes Vaccine 16 1998 1828 1835
29. V.K. Kuchroo, M.P. Das, J.A. Brown, A.M. Ranger, S.S. Zamvil, R.A. Sobel, H.L. Weiner, N. Nabavi, and L.H. Glimcher B7-1 and B7-2 costimulatory molecules activate differentially the Thl/Th2 developmental pathways: application to autoimmune disease therapy Cell 80 1995 707 718
30. D.R. Leach, M.F. Krummel, and J.P. Allison Enhancement of antitumor immunity by CTLA-4 blockade Science 271 1996 1734 1736
31. P.S. Linsley, W. Brady, L. Grosmaire, A. Aruffo, N.K. Damle, and J.A. Ledbetter Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interfeukin 2 mRNA accumulation J. Exp. Med. 173 1991 721 730
32. F. Lohr, K. Hu, Z. Haroon, T.V. Samulski, Q. Huang, J. Beaty, M.W. Dewhirst, and C.Y. Li Combination treatment of murine tumors by adenovirus-mediated local B7/IL12 immunotherapy and radiotherapy Mol. Ther. 2 2000 195 203
33. M. Mackett, G.L. Smith, and B. Moss General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes J. Virol. 49 1984 857 864
34. K.W. Marshall, and J.D. Marks Engineering and characterization of a novel fusion protein incorporating B7.2 and an anti-ErbB-2 single-chain antibody fragment for the activation of Jurkat T cells J. Immunother. 24 2001 27 36
35. P.J. Martin, J.A. Ledbetter, Y. Morishita, C.H. June, P.G. Beatty, and J.A. Hansen A 44 kilodalton cell surface homodimer regulates interleukin 2 production by activated human T lymphocytes J. Immunol. 136 1986 3282 3287
36. R.F. Massung, and R.W. Moyer The molecular biology of swinepox virus I. A characterization of the viral DNA Virology 180 1991 347 354
37. U. Matulonis, C. Dosiou, G. Freeman, C. Lamont, P. Mauch, L.M. Nadler, and J.D. Griffin B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct J. Immunol. 156 1996 1126 1131
38. A.J. McAdam, E.A. Farkash, B.E. Gewurz, and A.H. Sharpe B7 costimulation is critical for antibody class switching and CD8(+) cytotoxic T-lymphocyte generation in the host response to vesicular stomatitis virus J. Virol. 74 2000 203 208
39. + T cells Immunol. Rev. 165 1998 231 247
40. R.S. McHugh, W.D. Ratnoff, R. Gilmartin, K.W. Sell, and P. Selvaraj Detection of a soluble form of B7-1 (CD80) in synovial fluid from patients with arthritis using monoclonal antibodies against distinct epitopes of human B7-1 Clin. Immunol. Immunopathol. 87 1998 50 59
41. Y. Nishimura, M. Shanojirna, T. Miyazawa, E. Sato, K. Nakamura, Y. Izumiya, Y. flceda, T. Mikami, and E. Takahashi Molecular cloning of the cDNAs encoding the feline B-lymphocyte activation antigen B7-1 (CD80) and B7-2 (CD86) homologues which interact with human CTLA4-Ig Eur. J. Immunogenet. 27 2000 427 430
42. B.M. Putzer, M. Hitt, W.J. Muller, P. Emtage, J. Gauidie, and F.L. Graham Interleukin 12 and B7-1 costimuiatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression Proc. Natl. Acad. Sci. U.S.A. 94 1997 10889 10894
43. J.B. Rao, R.S. Chamberlain, V. Bronte, M.W. Carroll, K.R. Irvine, B. Moss, S.A. Rosenberg, and N.P. Restifo IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression J. Immunol. 156 1996 3357 3365
44. P. Rennert, K. Furlong, C. Jellis, E. Greenfield, G.J. Freeman, Y. Ueda, B. Levine, C.H. June, and G.S. Gray The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion Int. Immunol. 9 1997 805 813
45. K. Runyon, K. Lee, K. Zuberek, M. Collins, J.P. Leonard, and K. Dunussi-Joannopoulos The combination of chemotherapy and systemic immunotherapy with soluble B7-immunoglobulin G leads to cure of murine leukemia and lymphoma and demonstration of tumor-specific memory responses Blood 97 2001 2420 2426
46. B. Salomon, and J.A. Bluestone Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation Annu. Rev. Immunol. 19 2001 225 252
47. S. Santra, D.H. Barouch, S.S. Jackson, M.J. Kuroda, J.E. Schmitz, M.A. Lifton, A.H. Sharpe, and N.X. Letvin Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses J. Immunol. 165 2000 6791 6795
48. S. Santra, D.H. Barouch, A.H. Sharpe, and N.L. Letvin B7 co-stimulatory requirements differ for induction of immune responses by DNA, protein and recombinant pox virus vaccination Eur. J. Immunol. 30 2000 2650 2659
49. P. Shankar, J. Schlom, and J.W. Hodge Enhanced activation of rhesus T cells by vectors encoding a triad of costimulatory molecules (B7-1, ICAM-1, LFA-3) Vaccine 20 2001 744 755
50. G.L. Smith, and B. Moss Infectious poxvirus vectors have capacity for at least 25,000 base pairs of foreign DNA Gene 25 1983 21 28
51. A.I. Sperling, J.A. Auger, B.D. Ehst, I.C. Rulifson, C.B. Thompson, and J.A. Bluestone CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation J. Immunol. 157 1996 3909 3917
52. K. Sturmhoefel, K. Lee, G.S. Gray, J. Thomas, R. Zollner, M. OToole, H. Swiniarski, A. Dorner, and S.F. Wolf Potent activity of soluble B7-IgG fusion proteins in therapy of established tumors and as vaccine adjuvant Cancer Res. 59 1999 4964 4972
53. J. Sule-Suso, F. Arienti, C. Melani, M.P. Colombo, and G. Parmiani A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytes Eur. J. Immunol. 25 1995 2737 2742
54. L.G. Thebeau, and L.A. Morrison B7 costimulation plays an important role in protection from herpes simplex virus type 2-mediated pathology J. Virol. 76 2002 2563 2566
55. T. Todo, R.L. Martuza, M.J. Dallman, and S.D. Rabkin In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity Cancer Res. 61 2001 153 161
56. M.B. Tompkins, M.E. Bull, J.L. Dow, J.M. Ball, E.W. Collisson, B.J. Winslow, A.P. Phadke, T.W. Vahlenkamp, and W.A. Tompkms Feline immunodeficiency virus infection is characterized by B7+CTLA4+ T cell apoptosis J. Infect. Dis. 185 2002 1077 1093
57. H. Towbin, T. Staehelin, and J. Gordon Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications Proc. Natl. Acad. Sci. U.S.A. 76 1979 4350 4354
58. T. Tsuji, K. Hamajima, N. Ishii, I. Aoki, J. Fukushima, K.Q. Xin, S. Kawamoto, S. Sasaki, K. Matsunaga, Y. Ishigatsubo, K. Tani, T. Okubo, and K. Okuda Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen Eur. J. Immunol. 27 1997 782 787
59. T.L. Walunas, C.Y. Bakker, and J.A. Bluestone CTLA-4 ligation blocks CD28-dependent T cell activation J. Exp. Med. 183 1996 2541 2550
60. T.L. Walunas, D.J. Lenschow, C.Y. Bakker, P.S. Linsley, G.J. Sreeman, J.M. Green, C.B. Thompson, and J.A. Bluestone CTLA-4 can function as a negative regulator of T cell activation Immunity 1 1994 405 413
61. B.J. Winslow, M.D. Cochran, A. Holzenburg, J. Sun, D.E. Junker, and E.W. Collisson Replication and expression of a swinepox virus vector delivering feline leukemia virus Gag and Env to cell lines of swine and feline origin Virus Res. 98 2003 1 15
62. S. Yang, and G.-K. Sim New forms of canine CD80 and CD86 transcripts that encode secreted B7 molecules Immunogenetics 50 1999 349 353
63. S. Yang, K.S. Sellins, T. Powell, E. Stoneman, and G.K. Sim Novel transcripts encoding secreted forms of feline CD80 and CD86 costimulatory molecules Vet. Immunol. Immunopathol. 81 2001 15 21